Incontinence-associated dermatitis: reducing adverse events
نویسندگان
چکیده
منابع مشابه
Incontinence-associated Dermatitis: Adverse Event Sequelae, Cost and Prevention
Incontinence-associated dermatitis (IAD) is a common problem in patients with faecal and/or urinary incontinence. Urine alters the normal skin flora and increases permeability of the stratum corneum and faecal enzymes on the skin contribute to skin damage. Faecal bacteria can then penetrate the skin, increasing the risk of secondary infection. However, IAD can be prevented and healed with timel...
متن کاملReducing Adverse Events and Hospitalizations Associated with Drug Interactions
A drug-drug interaction is a pharmacokinetic or pharmacodynamic influence of one drug on another, which can reduce the effectiveness of one or both of the interacting drugs or can lead to toxic effects.1 It is estimated that such drug interactions cause up to 2.8% of hospital admissions,2 and they can lead to serious adverse outcomes for patients. One drug combination that has resulted in death...
متن کاملPrevention and management of incontinence-associated dermatitis.
David Voegeli, Associate Professor of Nursing, Skin Health Research Group, Faculty of Health Sciences, University of Southampton, discusses the care of patients with incontinence-associated dermatitis and how to distinguish this condition from pressure ulcers.
متن کاملBisphosphonate-associated adverse events.
The adverse events of the nitrogen-containing bisphosphonates are reviewed. Oral bisphosphonates (alendronate, risedronate and ibandronate), mainly used for the treatment of osteoporosis, have been associated with adverse events from the upper gastrointestinal tract, acute phase response, hypocalcaemia and secondary hyperparathyroidism, musculoskeletal pain, osteonecrosis of the jaw and ocular ...
متن کاملReducing adverse events in blood transfusion.
Against a background of ever increasing expenditure on blood safety, less attention has been paid to improving the safety of the transfusion chain within hospitals. Based on reports to the Serious Hazards of Transfusion (SHOT scheme) between 1996 and 2003, the risk of an error occurring during transfusion of a blood component is estimated at 1:16 500, an ABO incompatible transfusion at 1:100 00...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Nursing
سال: 2016
ISSN: 0966-0461,2052-2819
DOI: 10.12968/bjon.2016.25.18.1016